These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 15452226)
1. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. Zhang Y; Simpson AA; Ledford RM; Bator CM; Chakravarty S; Skochko GA; Demenczuk TM; Watanyar A; Pevear DC; Rossmann MG J Virol; 2004 Oct; 78(20):11061-9. PubMed ID: 15452226 [TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site. Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14. Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640 [TBL] [Abstract][Full Text] [Related]
4. A novel benzonitrile analogue inhibits rhinovirus replication. Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704 [TBL] [Abstract][Full Text] [Related]
5. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887 [TBL] [Abstract][Full Text] [Related]
6. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115 [TBL] [Abstract][Full Text] [Related]
7. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity. Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522 [TBL] [Abstract][Full Text] [Related]
9. Human rhinovirus capsid dynamics is controlled by canyon flexibility. Reisdorph N; Thomas JJ; Katpally U; Chase E; Harris K; Siuzdak G; Smith TJ Virology; 2003 Sep; 314(1):34-44. PubMed ID: 14517058 [TBL] [Abstract][Full Text] [Related]
10. The structure of human rhinovirus 16. Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan. Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152 [TBL] [Abstract][Full Text] [Related]
12. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril. Ledford RM; Collett MS; Pevear DC Antiviral Res; 2005 Dec; 68(3):135-8. PubMed ID: 16199099 [TBL] [Abstract][Full Text] [Related]
13. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Smith TJ; Kremer MJ; Luo M; Vriend G; Arnold E; Kamer G; Rossmann MG; McKinlay MA; Diana GD; Otto MJ Science; 1986 Sep; 233(4770):1286-93. PubMed ID: 3018924 [TBL] [Abstract][Full Text] [Related]
14. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14. Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772 [TBL] [Abstract][Full Text] [Related]
15. Antiviral agent blocks breathing of the common cold virus. Lewis JK; Bothner B; Smith TJ; Siuzdak G Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6774-8. PubMed ID: 9618488 [TBL] [Abstract][Full Text] [Related]
16. Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses. Egorova A; Kazakova E; Jahn B; Ekins S; Makarov V; Schmidtke M Eur J Med Chem; 2020 Feb; 188():112007. PubMed ID: 31881489 [TBL] [Abstract][Full Text] [Related]
17. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG Proteins; 1989; 6(1):1-19. PubMed ID: 2558377 [TBL] [Abstract][Full Text] [Related]
18. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain. Hussain Basha S; Prasad RN BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192 [TBL] [Abstract][Full Text] [Related]
19. Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization. Andries K; Dewindt B; Snoeks J; Willebrords R Arch Virol; 1989; 106(1-2):51-61. PubMed ID: 2548460 [TBL] [Abstract][Full Text] [Related]
20. Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance. Basta HA; Ashraf S; Sgro JY; Bochkov YA; Gern JE; Palmenberg AC Virology; 2014 Jan; 448():82-90. PubMed ID: 24314639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]